Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: A case report
Pan African Medical Journal, cilt.38, ss.1-5, 2021 (ESCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 38
- Basım Tarihi: 2021
- Doi Numarası: 10.11604/pamj.2021.38.17.27507
- Dergi Adı: Pan African Medical Journal
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.1-5
- Anahtar Kelimeler: Ectopic pregnancy, methotrexate, medical therapy, pharmacogenetics, case report
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single low-dose methotrexate for the treatment of ectopic pregnancy. Febrile neutropenia developed on day 4 of single-dose methotrexate administered intramuscularly. Although methotrexate single-dose regimen is quite effective and safe in ectopic pregnancy, febrile neutropenia can occur very rarely.